154
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Uterine Artery Embolization with Small-Sized Particles for the Treatment of Symptomatic Adenomyosis: A 42-Month Clinical Follow-Up

, , , , , , , , & show all
Pages 3575-3581 | Published online: 15 Jul 2021

References

  • Antero MF, Ayhan A, Segars J, Shih IM. Pathology and pathogenesis of adenomyosis. Semin Reprod Med. 2020;38(2–03):108–118. doi:10.1055/s-0040-1718922
  • Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(5):592–632.
  • Upson K, Missmer SA. Epidemiology of Adenomyosis. Semin Reprod Med. 2020;38(2–03):89–107. doi:10.1055/s-0040-1718920
  • de Bruijn AM, Lohle PN, Huirne JA, de Vries J, Twisk M, Hehenkamp WJ; QUESTA-Trial Group. Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA Trial. JMIR Res Protoc. 2018;7(3):e47. doi:10.2196/resprot.8512
  • Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–137. doi:10.1016/j.bpobgyn.2018.01.016
  • Dessouky R, Gamil SA, Nada MG, Mousa R, Libda Y. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging. 2019;10(1):48. doi:10.1186/s13244-019-0732-8
  • Popovic M, Puchner S, Berzaczy D, Lammer J, Bucek RA. Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol. 2011;22(7):901–909. doi:10.1016/j.jvir.2011.03.013
  • Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata.. Obstet Gynecol. 2002;99(2):290–300. doi:10.1016/s0029-7844(01)01702-1
  • de Bruijn AM, Smink M, Hehenkamp WJK, et al. Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire. Cardiovasc Intervent Radiol. 2017;40(9):1344–1350. doi:10.1007/s00270-017-1686-1
  • Angle JF, Siddiqi NH, Wallace MJ, et al.; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for percutaneous transcatheter embolization: society of interventional radiology standards of practice committee. J Vasc Interv Radiol. 2010;21(10):1479–1486. doi:10.1016/j.jvir.2010.06.014
  • Smeets AJ, Nijenhuis RJ, Boekkooi PF, Vervest HAM, van Rooij WJ, Lohle PNM. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol. 2012;35(4):815–819. doi:10.1007/s00270-011-0203-1
  • Bae SH, Kim MD, Kim GM, et al. Uterine artery embolization for adenomyosis: percentage of necrosis predicts midterm clinical recurrence. J Vasc Interv Radiol. 2015;26(9):1290–1296. doi:10.1016/j.jvir.2015.04.026
  • Kim MD. Uterine artery embolization for leiomyomas and adenomyosis: a pictorial essay based on our experience from 1300 cases. Korean J Radiol. 2019;20(10):1462–1473. doi:10.3348/kjr.2019.0205
  • de Bruijn AM, Smink M, Lohle PNM, et al. Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. J Vasc Interv Radiol. 2017;28(12):1629–1642. doi:10.1016/j.jvir.2017.07.034
  • Kossaï M, Penault-Llorca F. Role of hormones in common benign uterine lesions: endometrial polyps, leiomyomas, and adenomyosis. Adv Exp Med Biol. 2020;1242:37–58.
  • Bourdon M, Santulli P, Jeljeli M, et al. Immunological changes associated with adenomyosis: a systematic review. Hum Reprod Update. 2021;27(1):108–129. doi:10.1093/humupd/dmaa038
  • Huo ZF, Chen CL, Liu P, et al. Analysis of related factors on effects of uterine artery embolization in the treatment of dysmenorrhea of adenomyosis and the construction and validation of prediction model. Zhonghua Fu Chan Ke Za Zhi. 2016;51(9):650–656. doi:10.3760/cma.j.issn.0529-567X.2016.09.003
  • Taran FA, Stewart EA, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013;73(9):924–931. doi:10.1055/s-0033-1350840
  • Froeling V, Scheurig-Muenkler C, Hamm B, Kroencke TJ. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment. Cardiovasc Intervent Radiol. 2012;35(3):523–529. doi:10.1007/s00270-011-0254-3